Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
2019
The MUSASHI (MSI) family of
RNA binding proteins(MSI1 and MSI2) contribute to a wide spectrum of cancers including acute
myeloid leukemia. We find that the
small moleculeRo 08–2750 (Ro) binds directly and selectively to MSI2 and competes for its RNA binding in biochemical assays. Ro treatment in mouse and human
myeloid leukemiacells results in an increase in differentiation and apoptosis, inhibition of known MSI-targets, and a shared global gene expression signature similar to shRNA depletion of MSI2. Ro demonstrates in vivo inhibition of c-MYC and reduces
disease burdenin a murine AML leukemia model. Thus, we identify a
small moleculethat targets MSI’s oncogenic activity. Our study provides a framework for targeting
RNA binding proteinsin cancer.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
84
References
46
Citations
NaN
KQI